Home > Healthcare > Medical Devices > Diagnostic Devices > Sperm Count Test Market

Sperm Count Test Market Size

  • Report ID: GMI5634
  • Published Date: May 2023
  • Report Format: PDF

Sperm Count Test Market Size

Sperm Count Test Market size was valued at over USD 2 billion in 2022 and is projected to witness over 5.3% CAGR from 2023 to 2032 due to increasing awareness about male infertility across globe.

 

 

A sperm count test, also known as semen analysis, is a diagnostic test used to measure the quality and quantity of sperm in a man's semen. It is typically ordered by a healthcare provider to assess a man's fertility or to diagnose potential fertility problems. A sperm count test can provide important information about a man's fertility potential and may help guide treatment options for couples experiencing infertility.
 

Increasing awareness regarding fertility testing devices is a key driver of market growth. According to the World Health Organization (WHO), infertility affects approximately 15% of couples worldwide, with male factors accounting for up to 50% of cases. This has led to a growing focus on male infertility and the importance of sperm count testing in identifying the cause of infertility.
 

In addition, several healthcare organizations and advocacy groups are taking initiatives to raise awareness about male infertility and the importance of fertility testing. These efforts include campaigns to educate the public about the causes and risk factors of male infertility, and the availability and benefits of sperm count testing.
 

 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Sperm count test industry size was over USD 2 billion in 2022 and will reach more than USD 3 billion by 2032 due to the surging awareness regarding fertility testing worldwide.

Sperm count test market microscopy technique segment exceeded USD 900 million in 2022 and will record more than USD 1,530 million by 2032 owing to the growing need for the visualization and analysis of sperm cells.

Demand for sperm count tests in the U.S. surpassed USD 785 million in 2022 and will record more than USD 1,233 million by 2032 due to the presence of favourable regulatory environment in the region.

Medical Electronic Systems, Fertility Focus Inc, Andrology Solutions, Vitrolife AB, DxNow, Hamilton Thorne, Artron Laboratories, Inc., ExSeed Health, Olympus Corporation, Inc., and AB ANALITICA s.r.l., are some of the well-known sperm count test companies.

Sperm Count Test Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 273
  • Countries covered: 30
  • Pages: 200
 Download Free Sample